Abstract
This systematic review and meta-analysis aimed to investigate the incidence of new-onset gastroesophageal reflux, reflux change, esophagitis, Barrett’s esophagus, and revision due to reflux, gastritis, and marginal ulcer after one-anastomosis gastric bypass (OAGB). We performed subgroup analyses based on primary and revisional OAGB and time of follow-up. Meta-analysis of 87 studies with 27,775 patients showed a 6% rate of new-onset reflux after OAGB. Preoperative reflux status did not change significantly after OAGB. The rate of esophagitis and Barrett’s esophagus was 15% and 1%, respectively. The new-onset reflux rate after OAGB was significantly higher than gastric bypass but not different with sleeve gastrectomy. The current study showed a relatively low rate of reflux and its complications after OAGB, but it was significantly higher than Roux-en-Y gastric bypass.
Graphical abstract
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
One-anastomosis gastric bypass (OAGB) is the third most common bariatric procedure globally after sleeve gastrectomy and Roux-en-Y gastric bypass (RYGB) [1]. OAGB was first mentioned by Rutledge et al. in 1997 as a modified type of standard RYGB [2]. OAGB has several advantages leading to advocacy for its wider adoption including a shorter learning curve, technical simplicity, the possibility of conversion to another bariatric type, and good weight loss and resolution rate of obesity-related comorbidities [3]. Due to promising results and low risk of complications, the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) and the American Society for Metabolic & Bariatric Surgery (ASMBS) have endorsed OAGB as a bariatric/metabolic procedure [4].
However, there is still some concern about post-OAGB reflux and other complications such as esophagitis, Barrett’s esophagus, and its association with adenocarcinoma, gastritis, and marginal ulcer after OAGB [5,6,7,8,9]. In addition, the incidence of reflux and its complications were reported in a wide range after OAGB. One group of studies reported a high rate of reflux up to 28% [10,11,12]. On the other hand, some studies showed a low rate of reflux and its consequences after OAGB [13,14,15]. Also, the effect of primary or revisional surgery on the incidence of reflux and its complications is not clear yet. The current systematic review and meta-analysis aimed to investigate the incidence of new-onset gastroesophageal reflux, reflux change after OAGB, marginal ulcer, esophagitis, Barrett’s esophagus, gastritis, and revision due to reflux after OAGB. Furthermore, the incidence of new-onset reflux was compared between OAGB and two other weight loss surgeries, sleeve gastrectomy and RYGB.
Methods
Search Strategy
Relevant studies were identified by conducting a comprehensive search by using Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines until Jan 15, 2023. PubMed, Embase, Web of Science, and Scopus databases were searched by using the following keywords: (“One anastomosis gastric bypass” OR “OAGB” OR “Single-anastomosis gastric bypass” OR “Single anastomosis gastric bypass” OR “Mini gastric bypass” OR “MGB” OR “omega loop gastric bypass” OR “loop gastric bypass”) AND (“bile reflux” OR “Reflux” OR “gastroesophageal reflux” OR “GERD” OR “Barrett” OR “Barrett’s” OR “Barretts”). Also, a manual search was done by assessing the references of related articles. There was no published year or language limit for the search process.
Inclusion and Exclusion Criteria
For initial inclusion, we included all the observational (retrospective and prospective) and randomized controlled trial (RCT) studies reporting the incidence of new-onset reflux, reflux change, marginal ulcer, esophagitis, Barrett’s esophagus, gastritis, or revision due to reflux after OAGB. Exclusion criteria were non-English studies, abstracts, conference abstracts, editorial letters, case studies, reviews, and meta-analyses. Studies with patients under 18 years of age were also excluded.
Study Selection
Literature search and study selection have been evaluated independently by two authors (AE and TZ) which were blinded to each other’s evaluation. After removing the duplicated studies, titles and abstracts were fully screened if they met the eligibility criteria. In addition, a third reviewer (ZK) resolved any kind of disagreement by discussion and consensus.
Quality Assessment
The quality assessment process was performed by two independent reviewers (AE and SA), and any discrepancies were solved by further discussion with the third reviewer (ZK). For the assessment of the quality of studies, the Joanna Briggs Institute (JBI) quality score (maximum score of 13) was used for the RCT studies. Also, the National Institutes of Health quality assessment tool for before-after studies (maximum score of 12) was used for the quality assessment of observational studies [16]. The quality scores are reported in Table 1.
Data Extraction and Subgroup Analysis
Two independent reviewers (AE and TZ) extracted the related data. The extracted data included author, year, country, study design, age, gender, sample size, time of follow-up, preoperative body mass index (BMI), type of surgery (primary or revision), previous bariatric surgery (in case of revisional surgery), surgery technique (size of bougie, length of biliopancreatic (BP) limb, pouch size, and concurrent anti-reflux procedures), postoperative PPI prescription, method of reflux detection, the incidence of new-onset reflux, reflux change, marginal ulcer, esophagitis (Los Angeles (LA) grade of esophagitis), Barrett’s esophagus, gastritis, and revision due to reflux. In addition, subgroup analyses were performed based on time of follow-up (shorter or longer than 5 years), design of the study (observational or RCT), and type of OAGB (as primary or revisional surgery).
Statistical Analysis
Stata Software version 17 (Stata Corp LCC, TX) was used for statistical analysis. The heterogeneity was calculated with I2, in which I2 lower than 50% shows non-severe heterogeneous variables and I2 more than 50% presents severe heterogeneous variables. Fixed and random effect analyses were used for the meta-analysis of non-severe and severe heterogeneous variables, respectively. The incidence rate was presented with a 95% confidence interval (CI). A P-value lower than 0.05 is considered significant. A random effects meta-regression model was performed to find any association between sample size, age, preoperative BMI, size of bougie, and length of the BP limb with the main variables.
Publication Bias
To minimize the impact of publication bias on the results of our meta-analyses, we conducted a comprehensive assessment using a range of established statistical methods. Specifically, we employed funnel plots, Egger’s linear regression test, and trim and fill analysis for each of the outcomes examined, including new-onset reflux, reflux change, marginal ulcer, esophagitis, Barrett’s esophagus, gastritis, and revision due to reflux. Funnel plots were used for detecting any asymmetry in the plot suggesting potential publication bias. Also, Egger’s linear regression test estimates the degree of funnel plot asymmetry using a regression model. In the case of identified funnel plot asymmetry, we employed trim and fill analysis. This method identifies potentially missing studies and imputes their effect sizes, enabling us to estimate the impact of these studies on the overall meta-analysis results.
Results
Study Characteristics
The systematic search of PubMed, Scopus, Embase, and Web of Science databases results in 1330 articles. After removing 616 duplicated articles, 718 remaining articles were assessed by title and abstract, and 568 articles were excluded per study protocol. The remaining 150 articles were reviewed in full text, and 87 articles met the inclusion criteria and were included in the final analysis. A total of 64, 15, and 8 studies were retrospective, prospective, and RCT, respectively. A total of 27,775 patients who underwent OAGB were included in this study. Figure 1 shows the PRISMA flowchart. The general characteristics and surgical techniques of the included studies are summarized in Table 1 and supplementary table 1, respectively. In addition, Table 2 presents the results of the pooled analysis in total and subgroups after OAGB.
New-Onset Reflux (De Novo Reflux)
Pooled random effects analysis of 70 articles showed a 6% rate of new-onset reflux after OAGB (95% CI 4–8%, I2 = 94.9%, P < 0.001) (Fig. 2) [10, 12,13,14,15, 17,18,19,20, 22,23,24,25, 27, 31, 34, 36,37,38,39,40,41, 44,45,46, 48, 50, 52, 53, 55, 58, 59, 62,63,64,65,66,67, 69,70,71,72,73,74, 76,77,78,79, 81, 83, 85,86,87, 89, 91,92,93, 96,97,98]. In addition, subgroup analysis of studies based on types of surgery showed OAGB as primary and revisional surgery resulted in 4% (95% CI 3–6%, I2 = 91.1%, and P < 0.001) and 10% (95% CI 8–13%, I2 = 75%, P < 0.001) rate of new-onset reflux, respectively (Supplementary Figure 1 and 2).
Change in Reflux Before and After Surgery
Twenty-nine articles reported pre- and postoperative reflux [10, 11, 13,14,15, 18, 23, 24, 32, 33, 36, 41,42,43,44,45,46, 51, 55,56,57, 62, 63, 74, 79, 81, 90]. The results showed that reflux change was insignificant in patients who underwent OAGB (OR = 0.59, 95% CI 0.28–1.26, I2 = 96.6%, P = 0.17) (Supplementary Figure 3). However, subgroup analysis based on types of surgery demonstrated that reflux did not change significantly after primary OAGB (OR = 1.21, 95% CI 0.39–3.79, P = 0.74), while it reduced significantly after OAGB as revisional surgery (OR = 0.26, 95% CI 0.1–0.7, P = 0.01) (Supplementary Figures 4 and 5).
Gastritis
Sixteen studies reported the rate of postoperative gastritis after OAGB [14, 24, 26, 28, 31, 35, 37, 43, 56, 57, 60, 61, 79, 88] which was 15% in pooled analysis (95% CI 8–23%, I2 = 87.6%, P < 0.001) (Supplementary Figure 6). In subgroup analysis, gastritis was found in 17% of patients who underwent OAGB as primary surgery (95% CI 8–27%, I2 = 88.3%, P < 0.001) (Supplementary Figure 7).
Esophagitis
Postoperative esophagitis was reported in 23 studies [11, 18, 19, 21, 22, 24, 26, 28, 31, 35, 43, 47, 52, 56,57,58, 79, 84, 85, 92]. The pooled random effects analysis revealed that esophagitis was diagnosed in 15% of patients with OAGB (95% CI 5–28%, I2 = 97.4%, P < 0.001) (Supplementary Figure 8). Subgroup analysis based on the grade of esophagitis showed that mild (Los Angeles (LA) grade A and B) and severe (LA grade C and D) esophagitis were diagnosed in 13% and 1% of patients after OAGB (Supplementary Figures 9 and 10). Additionally, patients who underwent OAGB as primary and revisional surgery presented with 16% (95% CI 5–31%, I2 = 95.8%, P < 0.001) and 19% (95% CI 0–69%, I2 = 98.1%, P < 0.001) esophagitis, respectively (Supplementary Figures 11 and 12).
Barrett’s Esophagus
The pooled fixed effects analysis of 15 studies showed that the rate of Barrett’s esophagus was 1% after OAGB (95% CI 0–2%, I2 = 0%, P = 0.63) (Supplementary Figure 13) [11, 21, 22, 24, 28, 31, 35, 53, 56, 61, 79].
Marginal Ulcer
The pooled random effects analysis of 57 studies revealed that 3% of patients experienced marginal ulcers after OAGB (95% CI 2–4%, I2 = 87.2%, P < 0.01) (Supplementary Figure 14) [10, 12, 13, 15, 18, 20, 22,23,24,25, 27, 31, 34,35,36,37,38, 40, 41, 43, 49, 50, 52,53,54,55,56, 59, 63, 65, 67, 70, 71, 76, 77, 79,80,81,82,83,84,85,86,87, 89, 92, 94, 95]. Furthermore, marginal ulcers occurred in 3% of patients with primary OAGB (95% CI 2–4%, I2 = 87.7%, P < 0.01) and 2% of patients with revisional OAGB (95% CI 1–4%, I2 = 60.8%, P < 0.01) (Supplementary Figures 15 and 16).
Revisional Surgery Due to Severe Reflux
The pooled random effects analysis of 44 studies showed that 2% of patients with OAGB were converted to RYGB due to severe reflux (95% CI 1–3%, I2 = 89.7%, P < 0.01) (Supplementary Figures 17) [22,23,24,25, 27, 29, 30, 34,35,36,37, 39, 41, 43, 45, 48, 49, 52, 54, 56, 62,63,64, 67, 68, 70,71,72, 76, 78, 82,83,84, 86, 91, 92, 95, 96]. In addition, subgroup analysis demonstrated that 1% and 6% of patients who underwent OAGB as primary and revisional surgery were converted to RYGB due to severe reflux (95% CI 1–3%, I2 = 88.9%, P < 0.01) (95% CI 3–8%, I2 = 73.7%, P < 0.01), respectively (Supplementary Figures 18 and 19).
Comparison of OAGB with RYGB and Sleeve gastrectomy
The pooled fixed effect analysis of 22 studies showed that OAGB had a significantly higher incidence of new-onset reflux compared to RYGB (OR = 2.64, 95% CI 2.01–3.49, I2 = 42.8%, P < 0.01) [11, 15, 17, 18, 31, 33, 39, 44, 50, 57, 61, 63, 69, 74, 75, 77, 81, 89, 92, 93, 96]. In addition, the pooled random effects analysis of 13 studies showed that the incidence of postoperative new-onset reflux was not significantly different between OAGB and sleeve gastrectomy (P = 0.31) (Supplementary Figures 20 and 21).
Effect of Surgical Volume on New-Onset Reflux
Since meta-regression showed an inverse correlation between the rate of new-onset reflux and the sample size of studies, a subgroup analysis was performed based on the sample size of included studies. The rate of new-onset reflux was 7%, 7%, and 3% in studies with sample sizes of less than 100, 100–500, and more than 500 patients, respectively (Supplementary Figures 22, 23, and 24).
Meta-regression Analysis
To find potential cofounders (sample size, length of BP limb, bougie size, preoperative BMI, and age) for the aforementioned variables, the random effects meta-regression was used. The results showed that sample size, length of BP limb, and preoperative BMI were significantly inversely correlated with the incidence of new-onset reflux after OAGB (Z = −2.74, P = 0.006), (Z = −1.99, P = 0.047), and (Z = −2.31, P = 0.021) respectively. However, there was no significant correlation between other variables and these potential cofounders.
Sensitivity Analysis
The results of the sensitivity analysis showed that new-onset reflux, change in reflux, marginal ulcer, Barrett’s esophagus, and revisional surgery due to severe reflux were not influenced significantly by a single study. However, the gastritis rate reduced to 11% and 12% after removing Fahmy et al.’s and Genco et al.’s study respectively (Supplementary Figure 25) [56, 57]. In addition, sensitivity analysis showed that the esophagitis rate was influenced significantly by several studies (Supplementary Figure 26).
Publication Bias
The funnel plot of new-onset reflux is presented in Supplementary Figure 27. As shown, there is an asymmetry in studies with smaller sample sizes. In line with this result, the Egger test showed a significant effect of small sample size studies (P = 0.037). In addition, trim-and-fill analysis demonstrated that new-onset reflux incidence decreased to 4% (95% CI 3–5%). However, the Egger test did not show a significant effect of small sample size studies for other variables. Also, the results of the trim-and-fill analysis did not demonstrate missing studies for other variables.
Discussion
Obesity has a strong correlation with the incidence of reflux. In fact, 61% of patients with obesity suffer from reflux, and it was indicated that increasing BMI can result in erosive esophagitis which is strongly linked with Barrett’s esophagus and gastro-esophageal junction malignancy [99, 100]. Weight loss, especially after bariatric surgery, can improve reflux and patients’ quality of life [101, 102]. Nevertheless, some bariatric procedures may worsen reflux or cause new-onset reflux [103]. OAGB has advantages like a short learning curve and technical simplicity as mentioned, as well as improvement of comorbidities which lead to the popularity of this type of surgery [3]. However, reflux and its subsequent complications are the main concerns about OAGB. According to a recent survey, a considerable percentage of surgeons who do not conduct OAGB still maintain the belief that this particular procedure carries a heightened risk of developing gastric and/or esophageal cancers [104]. Hence, we conduct this systematic review and meta-analysis on 87 studies and 27,775 patients to investigate the rate of reflux and its complications in patients who underwent OAGB.
The pooled results of the current study showed that OAGB was associated with 6% of new-onset reflux. This result is constant in the pooled analysis of studies with short- and long-term (more than 5 years) follow-ups. OAGB as primary surgery for patients with obesity leads to 4% of new-onset reflux. On the other hand, OAGB as revisional surgery was followed by a 2.5 times higher (10%) incidence of new-onset reflux. Previous studies showed that preoperative reflux and revisional OAGB are risk factors for postoperative reflux after OAGB [41]. Therefore, patients who underwent revisional OAGB should be counseled before the surgery and monitored closely afterward.
Our study showed that OAGB had a significantly higher incidence of postoperative new-onset reflux compared to RYGB (OR = 2.64). Furthermore, although our analysis was unable to show a significant difference between OAGB and sleeve gastrectomy with regard to postoperative new-onset reflux, the 6% rate of new-onset reflux was lower than the 23% rate after sleeve gastrectomy reported in a meta-analysis by Yeung et al. [105]. The mechanism of reflux after OAGB is unclear. It was indicated that the sleeved shape of the gastric conduit can cause increased intra-gastric pressure according to Laplace’s law in which the pressure is inversely correlated with diameter in a poorly dilatable cylinder [19, 106]. Meantime, it has been stated that a long gastric pouch can decrease reflux [41, 50, 107].
One of the potential benefits of bariatric surgery is its ability to alleviate reflux symptoms in patients with obesity. Some studies showed the anti-reflux effect of OAGB in patients with preoperative reflux [13, 14]. Nevertheless, in the current study, the pooled results did not show a significant reduction in reflux incidence after OAGB in patients with preoperative reflux. In fact, in the previous experts’ consensus, 75% of experts disagree that the OAGB is a suitable option for patients with severe reflux [108]. Our study showed that in patients with preoperative reflux, revisional OAGB (after a failed restrictive bariatric surgery) is associated with a significantly reduced incidence of reflux postoperatively (OR = 0.26). Nevertheless, most of the failed restrictive bariatric surgery were sleeve gastrectomy in which the rate of postoperative reflux was high, and this result can be due to the better anti-reflux properties of OAGB compared to sleeve gastrectomy.
The most common complication of reflux is esophagitis. Reflux can also cause Barrett’s esophagus which is a precursor lesion to esophageal adenocarcinoma and is one of the main concerns about OAGB [109]. The results of our study showed that the incidence of postoperative esophagitis was 15% after OAGB. However, most of these cases were LA grade A and B esophagitis (13%). This result is almost half of what was previously reported for sleeve gastrectomy [105]. In a systematic review and meta-analysis of sleeve gastrectomy, the incidence of postoperative esophagitis was 30%, and in the subgroup analysis of long-term results, this rate was 28% [105]. However, in the current study, the rate of postoperative esophagitis was 19% in a subgroup analysis of studies with long-term follow-up (> 5 years). In addition, the rate of Barrett’s esophagus after OAGB was 1% in the current study which was lower than the 6% rate which was reported after sleeve gastrectomy [105]. The incidence of Barrett’s esophagus was 1% in pooled results of studies with long-term follow-up which is lower than the 8% rate of Barrett’s esophagus after sleeve gastrectomy in pooled results of studies with long-term follow-up [105]. However, in most of the included studies, esophagoduodenoscopy was performed only in patients with reflux symptoms. Therefore, esophagitis incidence and Barrett’s esophagus rate could be underestimated. In addition, gastritis as a potential complication of bile reflux was presented in 15% of patients with OAGB in the current study. These results imply the importance of the IFSO recommendation for sleeve gastrectomy regarding upper endoscopy at 1-year post-operation for all patients, followed by repeat surveillance every 2–3 years, regardless of reflux symptoms which may be also considered for OAGB [110].
Marginal ulcers are one the most important complications of bariatric surgery that can even lead to perforation and revisional surgery. Marginal ulcer seems to be the result of a combination of tissue ischemia, foreign body, and gastric acid. In fact, previous studies showed that cigarette smoking, small gastric pouch, NSAIDs, alcohol, and learning curve < 50 operations are the risk factors for developing marginal ulcers after OAGB [64, 98, 111,112,113,114]. The current study showed that the incidence rate of marginal ulcers was 3%. This result is also constant in the subgroup analysis of long-term follow-up (> 5 years) and RCT studies. This result is in accordance with the 2.8% marginal ulcer rate reported in a systematic review done by Mahawar et al. after OAGB and similar to RYGB [115]. In addition, in the current study, most of these marginal ulcers were treated by PPI, and there were a small number of patients who needed surgical intervention due to perforated marginal ulcers.
One of the important advantages of OAGB is its simplicity of reversal and revision [3, 116]. In fact, patients with irritable reflux who do not respond to high-dose PPI and lifestyle management may need revision surgery. RYGB is the surgical option of choice in patients with severe reflux. Previous studies showed that RYGB can significantly improve reflux and even its complications such as Barrett’s esophagus [117, 118]. In this study, the rate of revisional surgery due to reflux after OAGB was 2%. This rate did not change in the pooled analysis of long-term follow-up studies. However, this number is half of what was previously reported in the meta-analysis of sleeve gastrectomy [105].
However, most of the pooled analyses in the current study had heterogeneous results. In fact, the study’s sample size is a cofounder for heterogeneity of new-onset reflux. The results of the subgroup analysis based on the study sample size showed that studies with sample sizes of more than 500 have a 3% rate of new-onset reflux, while this result was about 7% for studies with lower sample sizes. Also, some studies reported an abnormally high rate of reflux after OAGB. In addition, as can be seen in supplementary Table 1, surgical technique and postoperative PPI use are quite different between included studies. With regards to these results and the varying correlation between OAGB and reflux, it can be suggested that surgeon experience and expertise, peri-operative management of patients such as PPI use, patient lifestyle, diet, and patient selection for OAGB can be potentially important factors for this variable reflux rate.
This is the largest meta-analysis with 27,775 patients with OAGB to assess the incidence of new-onset reflux, changes in reflux, esophagitis, Barrett’s esophagus, revision due to reflux, marginal ulcer, and gastritis. These findings can help current practices and guidelines. In addition, subgroup analyses based on the type of surgery, time of follow-up (less and more than 5 years), and design of studies (observational and RCT) were done to reduce heterogeneity and improve the reliability of the results.
This study has multiple limitations. The method of detection for reflux was different between the included studies (clinical symptoms, questionnaire, and upper endoscopy). Acid versus bile reflux was not differentiated in most studies. Additionally, most of the reported pooled analyses had heterogeneous results. We performed meta-regression and subgroup analysis to detect the source of heterogenicity and reduce it. Also, there was a lack of data regarding the standardization of perioperative management, surgical technique, and threshold for revisional surgery. Furthermore, the follow-up time was in a wide range between the included studies, and we had to perform a subgroup analysis based on the time of follow-up to solve this problem. It is highly recommended for future studies to investigate the potential factors that make patients with OAGB susceptible to reflux and its complications. Also, studies with long-term follow-up with upper endoscopy and pH-impedance testing are recommended.
Conclusion
The current study showed that the rate of new-onset reflux after OAGB is approximately 6%. Two percent of patients with OAGB needed revision due to severe reflux. However, patients who underwent OAGB as revisional surgery after failed restrictive bariatric surgery experience a higher rate of reflux (10%). Further research is needed on the mechanism of reflux after OAGB and how to prevent it.
Data availability
Interested researchers may request access to the data by contacting the corresponding author.
References
Angrisani L, Santonicola A, Iovino P, Vitiello A, Higa K, Himpens J, et al. IFSO worldwide survey 2016: primary, endoluminal, and revisional procedures. Obes Surg. 2018;28:3783–94.
Rutledge R, Kular K, Manchanda N. The mini-gastric bypass original technique. Int J Surg. 2019;61:38–41.
Mahawar KK, Kumar P, Carr WR, Jennings N, Schroeder N, Balupuri S, et al. Current status of mini-gastric bypass. J Minim Access Surg. 2016;12(4):305.
De Luca M, Tie T, Ooi G, Higa K, Himpens J, Carbajo M-A, et al. Mini gastric bypass-one anastomosis gastric bypass (MGB-OAGB)-IFSO position statement. Obes Surg. 2018;28:1188–206.
Fuchs K-H, Maroske J, Fein M, Tigges H, Ritter MP, Heimbucher J, et al. Variability in the composition of physiologic duodenogastric reflux. J Gastrointest Surg. 1999;3(4):389–96.
Fiorucci S, Distrutti E, Di Matteo F, Brunori P, Santucci L, Mallozzi E, et al. Circadian variations in gastric acid and pepsin secretion and intragastric bile acid in patients with reflux esophagitis and in healthy controls. Am J Gastroenterol (Springer Nat). 1995;90:2.
Zhang Y, Yang X, Gu W, Shu X, Zhang T, Jiang M. Histological features of the gastric mucosa in children with primary bile reflux gastritis. World J Surg Oncol. 2012;10:1–8.
Matsuhisa T, Arakawa T, Watanabe T, Tokutomi T, Sakurai K, Okamura S, et al. Relation between bile acid reflux into the stomach and the risk of atrophic gastritis and intestinal metaplasia: a multicenter study of 2283 cases. Dig Endosc. 2013;25(5):519–25.
Savarino E, Zentilin P, Frazzoni M, Cuoco D, Pohl D, Dulbecco P, et al. Characteristics of gastro-esophageal reflux episodes in Barrett’s esophagus, erosive esophagitis and healthy volunteers. Neurogastroenterol Motil. 2010;22(10):1061–e280.
de la Cruz M, Büsing M, Dukovska R, Torres AJ, Reiser M. Short-to medium-term results of single-anastomosis duodeno-ileal bypass compared with one-anastomosis gastric bypass for weight recidivism after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2020;16(8):1060–6.
Felsenreich DM, Arnoldner MA, Wintersteller L, Mrekva A, Jedamzik J, Eichelter J, Langer FB, Prager G. Intrathoracic pouch migration in one-anastomosis gastric bypass with and without hiatoplasty: a 3-dimensional-computed tomography volumetry study. Surg Obes Relat Dis. 2023;19(5):492–9.
Petrucciani N, Martini F, Benois M, Kassir R, Boudrie H, Van Haverbeke O, et al. Revisional one anastomosis gastric bypass with a 150-cm biliopancreatic limb after failure of adjustable gastric banding: mid-term outcomes and comparison between one-and two-stage approaches. Obes Surg. 2021;31:5330–41.
Kular K, Manchanda N, Rutledge R. A 6-year experience with 1,054 mini-gastric bypasses—first study from Indian subcontinent. Obes Surg. 2014;24:1430–5.
Carbajo MA, Luque-de-León E, Jiménez JM, Ortiz-de-Solórzano J, Pérez-Miranda M, Castro-Alija MJ. Laparoscopic one-anastomosis gastric bypass: technique, results, and long-term follow-up in 1200 patients. Obes Surg. 2017;27:1153–67.
Hany M, Zidan A, Elmongui E, Torensma B. Revisional Roux-en-Y gastric bypass versus revisional one-anastomosis gastric bypass after failed sleeve gastrectomy: a randomized controlled trial. Obes Surg. 2022;32(11):3491–503.
https://www.nhlbi.nih.gov/health-topics/studyquality-assessment-tools. Quality assessment tool for before-after (pre-post) studies with no control group. accessed date: Jan 30, 2030
Zarshenas N, Tapsell LC, Batterham M, Neale EP, Talbot ML. Changes in anthropometric measures, nutritional indices and gastrointestinal symptoms following one anastomosis gastric bypass (OAGB) compared with Roux-en-y gastric bypass (RYGB). Obes Surg. 2021;31(6):2619–31.
Wilczyński M, Spychalski P, Proczko-Stepaniak M, Bigda J, Szymański M, Dobrzycka M, et al. Comparison of the long-term outcomes of RYGB and OAGB as conversion procedures after failed LSG - a case-control study. J Gastrointest Surg. 2022;26(11):2255–65.
Tolone S, Musella M, Savarino E, Cristiano S, Docimo L, Deitel M. Esophagogastric junction function and gastric pressure profile after minigastric bypass compared with Billroth II. Surg Obes Relat Dis. 2019;15(4):567–74.
Tasdighi E, Mousapour P, Khalaj A, Sadeghian Y, Mahdavi M, Valizadeh M, et al. Comparison of mid-term effectiveness and safety of one-anastomosis gastric bypass and sleeve gastrectomy in patients with super obesity (BMI ≥ 50 kg/m2). Surg Today. 2022;52(5):854–62.
Szymański M, Marek I, Wilczyński M, Janczy A, Bigda J, Kaska Ł, et al. Evaluation of esophageal pathology in a group of patients 2 years after one-anastomosis gastric bypass (OAGB)—cohort study. Obes Res Clin Pract. 2022;16(1):82–6.
Soprani A, Zulian V, Nedelcu M, Carandina S. One-stage conversion of laparoscopic adjustable gastric banding to laparoscopic 1-anastomosis gastric bypass: a single-center experience on 1,000 patients at 5 years of follow-up. Surg Obes Relat Dis. 2022;18(5):650–7.
Sohrabi Maralani M, Azadnajafabad S, Elyasinia F, Abolhasani M, Bagheri M, Kor F, et al. Postoperative outcomes and advantages of hand-sewn laparoscopic one-anastomosis gastric bypass: experience on 805 patients. Obes Surg. 2021;31(2):627–33.
Slagter N, Hopman J, Altenburg AG, de Heide LJM, Jutte EH, Kaijser MA, et al. Applying an anti-reflux suture in the one anastomosis gastric bypass to prevent biliary reflux: a long-term observational study. Obes Surg. 2021;31(5):2144–52.
Shivakumar S, Tantia O, Goyal G, Chaudhuri T, Khanna S, Ahuja A, et al. LSG vs MGB-OAGB-3 year follow-up data: a randomised control trial. Obes Surg. 2018;28(9):2820–8.
Shenouda MM, Harb SEG, Mikhail SAA, Mokhtar SM, Osman AMA, Wassef ATS, et al. Bile gastritis following laparoscopic single anastomosis gastric bypass: pilot study to assess significance of bilirubin level in gastric aspirate. Obes Surg. 2018;28(2):389–95.
Schmitz SMT, Alizai PH, Kroh A, Schipper S, Brozat JF, Plamper A, et al. Clinical outcomes after one anastomosis gastric bypass versus sleeve gastrectomy in super-super-obese patients. Surg Endosc. 2022;36(6):4401–7.
Salama TMS, Hassan MI. Incidence of biliary reflux esophagitis after laparoscopic omega loop gastric bypass in morbidly obese patients. J Laparoendosc Adv Surg Tech A. 2017;27(6):618–22.
Maurice AP, Miron SW, Yaksich LR, Hopkins GH, Dodd BR. Revisional bariatric surgery to single-anastomosis gastric bypass: a large multi-institutional series. Surg Obes Relat Dis. 2021;17(6):1080–7.
Almuhanna M, Soong TC, Lee WJ, Chen JC, Wu CC, Lee YC. Twenty years' experience of laparoscopic 1-anastomosis gastric bypass: surgical risk and long-term results. Surg Obes Relat Dis. 2021;17(5):968–75.
Robert M, Espalieu P, Pelascini E, Caiazzo R, Sterkers A, Khamphommala L, et al. Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial. Lancet. 2019;393(10178):1299–309.
Rheinwalt KP, Schipper S, Plamper A, Alizai PH, Trebicka J, Brol MJ, et al. Roux-en-Y versus one anastomosis gastric bypass as redo-operations following sleeve gastrectomy: a retrospective study. World J Surg. 2022;46(4):855–64.
Rayman S, Assaf D, Azran C, Sroka G, Assalia A, Beglaibter N, et al. Sleeve gastrectomy failure—revision to laparoscopic one-anastomosis gastric bypass or Roux-n-Y gastric bypass: a multicenter study. Obes Surg. 2021;31(7):2927–34.
Plamper A, Lingohr P, Nadal J, Trebicka J, Brol MJ, Woestemeier A, et al. A Long-Term Comparative Study Between One Anastomosis Gastric Bypass and Sleeve Gastrectomy. J Gastrointest Surg. 2023;27(1):47–55.
Pizza F, Lucido FS, D’Antonio D, Tolone S, Gambardella C, Dell’Isola C, et al. Biliopancreatic limb length in one anastomosis gastric bypass: which is the best? Obes Surg. 2020;30(10):3685–94.
Parmar CD, Mahawar KK, Boyle M, Carr WRJ, Jennings N, Schroeder N, et al. Mini gastric bypass: first report of 125 consecutive cases from United Kingdom. Clin Obes. 2016;6(1):61–7.
Ospanov O, Buchwald JN, Yeleuov G, Bekmurzinova F. Laparoscopic one-anastomosis gastric bypass with band-separated gastric pouch (OAGB-BSGP): a randomized controlled trial. Obes Surg. 2019;29(12):4131–7.
Noun R, Skaff J, Riachi E, Daher R, Antoun NA, Nasr M. One thousand consecutive mini-gastric bypass: short- and long-term outcome. Obes Surg. 2012;22(5):697–703.
Mustafa A, Rizkallah NNH, Samuel N, Balupuri S. Laparoscopic Roux-En-Y gastric bypass versus one anastomosis (loop) gastric bypass for obesity: a prospective comparative study of weight loss and complications. Ann Med Surg (Lond). 2020;55:143–7.
Musella M, Bruni V, Greco F, Raffaelli M, Lucchese M, Susa A, et al. Conversion from laparoscopic adjustable gastric banding (LAGB) and laparoscopic sleeve gastrectomy (LSG) to one anastomosis gastric bypass (OAGB): preliminary data from a multicenter retrospective study. Surg Obes Relat Dis. 2019;15(8):1332–9.
Musella M, Susa A, Manno E, De Luca M, Greco F, Raffaelli M, et al. Complications following the mini/one anastomosis gastric bypass (MGB/OAGB): a multi-institutional survey on 2678 patients with a mid-term (5 years) follow-up. Obes Surg. 2017;27:2956–67.
Mahdy T, Gado W, Alwahidi A, Schou C, Emile SH. Sleeve gastrectomy, one-anastomosis gastric bypass (OAGB), and single anastomosis sleeve ileal (SASI) bypass in treatment of morbid obesity: a retrospective cohort study. Obes Surg. 2021;31(4):1579–89.
Liagre A, Martini F, Kassir R, Juglard G, Hamid C, Boudrie H, et al. Is one anastomosis gastric bypass with a biliopancreatic limb of 150 cm effective in the treatment of people with severe obesity with BMI > 50? Obes Surg. 2021;31(9):3966–74.
Level L, Rojas A, Piñango S, Avariano Y. One anastomosis gastric bypass vs. Roux-en-Y gastric bypass: a 5-year follow-up prospective randomized trial. Langenbeck's Arch Surg. 2021;406(1):171–9.
Kermansaravi M, Kabir A, Mousavimaleki A, Pazouki A. Association between hiatal hernia and gastroesophageal reflux symptoms after one-anastomosis/mini gastric bypass. Surg Obes Relat Dis. 2020;16(7):863–7.
Kermansaravi M, Karami R, Valizadeh R, Rokhgireh S, Kabir A, Pakaneh M, et al. Five-year outcomes of one anastomosis gastric bypass as conversional surgery following sleeve gastrectomy for weight loss failure. Sci Rep. 2022;12(1):10304.
Katayama RC, Arasaki CH, Herbella FAM, Neto RA, Lopes GD. One-anastomosis and Roux-en-Y gastric bypass promote similar weight loss, patient satisfaction, quality of life, inflammation grade, and cellular damage in the esophagus and gastric pouch in a short-term follow-up. J Obes Metab Syndr. 2021;30(4):396–402.
Kassir R, Giudicelli X, Lointier P, Breton C, Blanc P. Omega loop gastroileal bypass (OLGIBP/SAGI) versus one anastomosis gastric bypass (OAGB): medium-term results. Obes Surg. 2021;31(4):1597–602.
Kansou G, Lechaux D, Delarue J, Badic B, Le Gall M, Guillerm S, et al. Laparoscopic sleeve gastrectomy versus laparoscopic mini gastric bypass: one year outcomes. Int J Surg. 2016;33:18–22.
Jammu GS, Sharma R. A 7-year clinical audit of 1107 cases comparing sleeve gastrectomy, Roux-En-Y gastric bypass, and mini-gastric bypass, to determine an effective and safe bariatric and metabolic procedure. Obes Surg. 2016;26:926–32.
Doulami G, Triantafyllou S, Albanopoulos K, Natoudi M, Zografos G, Theodorou D. Acid and nonacid gastroesophageal reflux after single anastomosis gastric bypass. An objective assessment using 24-hour multichannel intraluminal impedance-pH metry. Surg Obes Relat Dis. 2018;14(4):484–8.
Hussain A, El-Hasani S. Short- and mid-term outcomes of 527 one anastomosis gastric bypass/mini-gastric bypass (OAGB/MGB) operations: retrospective study. Obes Surg. 2019;29(1):262–7.
Haggag M, Salem A, Sultan AM, Elghawalby AN, Eldesoky RT, Eldegwi SA, et al. Early and intermediate term outcomes after laparoscopic one-anastomosis gastric bypass for morbidly obese patients: a single center experience. Turk J Surg. 2021;37(4):324–35.
Gricks B, Eldredge T, Bessell J, Shenfine J. Outcomes of 325 one anastomosis gastric bypass operations: an Australian case series. ANZ J Surg. 2022;92(9):2123–8.
Gholizadeh B, Makhsosi BR, Valizadeh R, Pazouki A, Kermansaravi M. Safety and efficacy of one anastomosis gastric bypass on patients with severe obesity aged 65 years and above. Obes Surg. 2022;32(5):1610–6.
Genco A, Castagneto-Gissey L, Gualtieri L, Lucchese M, Leuratti L, Soricelli E, et al. GORD and Barrett’s oesophagus after bariatric procedures: multicentre prospective study. Br J Surg. 2021;108(12):1498–505.
Fahmy MH, Sarhan MD, Salman MA, Fathy E. Gastro-esophageal reflux disease after laparoscopic mini-gastric bypass and Roux-en-Y gastric bypass: is there a difference? Bariatr Surg Pract Patient Care. 2018;13(3):109–14.
Felsenreich DM, Steinlechner K, Langer FB, Vock N, Eichelter J, Bichler C, et al. Outcome of sleeve gastrectomy converted to Roux-en-Y gastric bypass and one-anastomosis Gastric bypass. Obes Surg. 2022;32(3):643–51.
Eskandaros MS. Outcomes and effects of 250-cm biliopancreatic limb one anastomosis gastric bypass in patients with BMI > 50 kg/m2 with total bowel length > 6 m: a 2-year follow-up. Obes Surg. 2022;32(7):2309–20.
Elmahdy TM, Elsherpiny WY, Barakat HB. Laparoscopic one anastomosis gastric bypass: a revisional procedure for failed laparoscopic sleeve gastrectomy. Surg Pract. 2022;26(2):101–7.
Eldredge TA, Bills M, Ting YY, Dimitri M, Watson MM, Harris MC, et al. Once in a bile — the incidence of bile reflux post-bariatric surgery. Obes Surg. 2022;32(5):1428–38.
Debs T, Petrucciani N, Kassir R, Juglard G, Gugenheim J, Iannelli A, et al. Laparoscopic conversion of sleeve gastrectomy to one anastomosis gastric bypass for weight loss failure: mid-term results. Obes Surg. 2020;30(6):2259–65.
Chiappetta S, Stier C, Scheffel O, Squillante S, Weiner RA. Mini/one anastomosis gastric bypass versus Roux-en-Y gastric bypass as a second step procedure after sleeve gastrectomy—a retrospective cohort study. Obes Surg. 2019;29(3):819–27.
Chevallier JM, Arman GA, Guenzi M, Rau C, Bruzzi M, Beaupel N, et al. One thousand single anastomosis (omega loop) gastric bypasses to treat morbid obesity in a 7-year period: outcomes show few complications and good efficacy. Obes Surg. 2015;25(6):951–8.
Charalampos T, Maria N, Vrakopoulou VGZ, Tania T, Raptis D, George Z, et al. Tailored one anastomosis gastric bypass: 3-year outcomes of 94 patients. Obes Surg. 2019;29(2):542–51.
Chakhtoura G, Zinzindohoué F, Ghanem Y, Ruseykin I, Dutranoy JC, Chevallier JM. Primary results of laparoscopic mini-gastric bypass in a French obesity-surgery specialized university hospital. Obes Surg. 2008;18(9):1130–3.
Carandina S, Soprani A, Zulian V, Cady J. Long-term results of one anastomosis gastric bypass: a single center experience with a minimum follow-up of 10 years. Obes Surg. 2021;31(8):3468–75.
Di Capua F, Uccelli M, Cesana GC, Oldani A, Olmi S. An unexpected high rate of internal hernia in our OAGB experience as revisional surgery for morbid obesity. Chirurgia (Bucur). 2021;116(5):609–19.
Cantay H, Binnetoglu K, Erdogdu UE, Firat YD, Cayci HM. Comparison of short- and long-term outcomes of bariatric surgery methods: a retrospective study. Medicine (Baltimore). 2022;101(38):e30679.
Bruzzi M, Rau C, Voron T, Guenzi M, Berger A, Chevallier JM. Single anastomosis or mini-gastric bypass: long-term results and quality of life after a 5-year follow-up. Surg Obes Relat Dis. 2015;11(2):321–6.
Bertrand T, Rives-Lange C, Jannot AS, Baratte C, de Castelbajac F, Lu E, et al. 150-cm versus 200-cm biliopancreatic limb one-anastomosis gastric bypass: propensity score–matched analysis. Obes Surg. 2022;32(9):2839–45.
Apers J, Wijkmans R, Totte E, Emous M. Implementation of mini gastric bypass in the Netherlands: early and midterm results from a high-volume unit. Surg Endosc. 2018;32(9):3949–55.
Abdallah E, Emile SH, Zakaria M, Fikry M, Elghandour M, AbdelMawla A, et al. One-anastomosis gastric bypass (OAGB) with fixed bypass of the proximal two meters versus tailored bypass of the proximal one-third of small bowel: short-term outcomes. Surg Endosc. 2022;36(1):328–35.
Abu Sneineh M, Abu Sneineh M, Abu Sneineh M, Abu Sneineh M, Abu Sneineh M, Abu SM. Sleeve gastrectomy is the most common cause of gastroesophageal reflux disease in comparison with other bariatric operations. Dig Dis. 2021;39(5):462–6.
Keleidari B, Mahmoudieh M, Jazi AHD, Melali H, Esfahani FN, Minakari M, et al. Comparison of the bile reflux frequency in one anastomosis gastric bypass and Roux-en-Y gastric bypass: a cohort study. Obes Surg. 2019;29(6):1721–5.
Poghosyan T, Alameh A, Bruzzi M, Faul A, Rives-Lange C, Zinzindohoue F, et al. Conversion of sleeve gastrectomy to one anastomosis gastric bypass for weight loss failure. Obes Surg. 2019;29(8):2436–41.
Rheinwalt KP, Plamper A, Rückbeil MV, Kroh A, Neumann UP, Ulmer TF. One anastomosis gastric bypass–mini-gastric bypass (OAGB-MGB) versus Roux-en-Y gastric bypass (RYGB)—a mid-term cohort study with 612 patients. Obes Surg. 2020;30(4):1230–40.
Neuberg M, Blanchet MC, Gignoux B, Frering V. Long-term outcomes after one-anastomosis gastric bypass (OAGB) in morbidly obese patients. Obes Surg. 2020;30(4):1379–84.
Saarinen T, Pietiläinen KH, Loimaala A, Ihalainen T, Sammalkorpi H, Penttilä A, et al. Bile reflux is a common finding in the gastric pouch after one anastomosis gastric bypass. Obes Surg. 2020;30(3):875–81.
Jamal MH, Elabd R, AlMutairi R, Albraheem A, Alhaj A, Alkhayat H, et al. The safety and efficacy of one anastomosis gastric bypass as a revision for sleeve gastrectomy. Obes Surg. 2020;30(6):2280–4.
Poublon N, Chidi I, Bethlehem M, Kuipers E, Gadiot R, Emous M, et al. One anastomosis gastric bypass vs. Roux-en-Y gastric bypass, remedy for insufficient weight loss and weight regain after failed restrictive bariatric surgery. Obes Surg. 2020;30(9):3287–94.
Kraljević M, Süsstrunk J, Köstler T, Lazaridis II, Zingg U, Delko T. Short or long biliopancreatic limb bypass as a secondary procedure after failed laparoscopic sleeve gastrectomy. Obes Surg. 2021;31(1):170–8.
Bashah M, Aleter A, Baazaoui J, El-Menyar A, Torres A, Salama A. Single anastomosis duodeno-ileostomy (SADI-S) versus one anastomosis gastric bypass (OAGB-MGB) as revisional procedures for patients with weight recidivism after sleeve gastrectomy: a comparative analysis of efficacy and outcomes. Obes Surg. 2020;30(12):4715–23.
Hussain A, Van den Bossche M, Kerrigan DD, Alhamdani A, Parmar C, Javed S, et al. Retrospective cohort study of 925 OAGB procedures. The UK MGB/OAGB collaborative group. Int J Surg. 2019;69:13–8.
Olmi S, Oldani A, Cesana G, Ciccarese F, Uccelli M, De Carli SM, et al. Laparoscopic one anastomosis gastric bypass versus laparoscopic one anastomosis gastric bypass with Braun anastomosis: what's better? J Laparoendosc Adv Surg Tech A. 2019;29(11):1469–74.
Acar F, Çolak B, Şahin M. Comparison of primer and revisional laparoscopic mini-gastric bypass (Mgb) for failed restrictive procedures: 2-year results at a tertiary center revsional mini-gastric gastric bypass (rmgbp) for failed restrictive procedures: 2-year results. Ann Clin Anal Med. 2021;12(2):124–8.
ElAbd R, AlMutairi R, Alhaj A, AlKhayat H, Jamal MH. One-anastomosis gastric bypass as a primary bariatric surgery: initial experience and short-term outcomes. Bariatr Surg Pract Patient Care. 2021;16(4):220–5.
Fetouh AE, Saber SA, Elmahdy T, Swelam A, Elgarf S, Abdallah HS, et al. Outcomes of laparoscopic one-anastomosis gastric bypass in treatment of morbid obesity: a retrospective analysis. Egypt J Surg. 2019;38(4):713–21.
Goel R, Nasta AM, Goel M, Prasad A, Jammu G, Fobi M, et al. Complications after bariatric surgery: a multicentric study of 11,568 patients from Indian bariatric surgery outcomes reporting group. J Minim Access Surg. 2021;17(2):213–20.
Mahfouz MF, Matar M, Salama TMS. Mini-gastric bypass versus single-anastomosis sleeve ileal bypass as revisional surgery after laparoscopic sleeve gastrectomy for gastroesophageal reflux disease management. Egypt J Surg. 2021;40(4):1229–32.
Zakaria M, Elhoofy A. Laparoscopic one-anastomosis gastric bypass: results of the first 310 patients. Egypt J Surg. 2019;38(3):406–10.
Soong TC, Lee MH, Lee WJ, Almalki OM, Chen JC, Wu CC, et al. Long-term efficacy of bariatric surgery for the treatment of super-obesity: comparison of SG, RYGB, and OAGB. Obes Surg. 2021;31(8):3391–9.
Nevo N, Lessing Y, Abu-Abeid S, Goldstein AL, Hazzan D, Nachmany I, et al. Roux-en-Y gastric bypass versus one anastomosis gastric bypass as a preferred revisional bariatric surgery after a failed silastic ring vertical gastroplasty. Obes Surg. 2021;31(2):654–8.
Winstanley J, Ahmed S, Courtney M, Sam M, Mahawar K. One anastomosis gastric bypass in patients with gastrooesophageal reflux disease and/or hiatus hernia. Obes Surg. 2021;31(4):1449–54.
Lee W-J, Yu P-J, Wang W, Chen T-C, Wei P-L, Huang M-T. Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity: a prospective randomized controlled clinical trial. Ann Surg. 2005;242(1):20.
Taha O, Abdelaal M, Asklany A, Alaa M. The outcomes of revisional one anastomosis gastric bypass versus revisional Roux-en-Y gastric bypass after primary restrictive procedures: a prospective nonrandomized comparative study. Bariatr Surg Pract Patient Care. 2022;17(3):155–61.
ElGohary H, Boshnak N, Alabassy E, Abdulrahman MG. Effect of gastrojejunal anastomosis diameter in laparoscopic one-anastomosis gastric bypass for the treatment of morbid obesity and related disorders: a comparative study. Egypt J Surg. 2021;40(4):1056–63.
Süsstrunk J, Wartmann L, Mattiello D, Köstler T, Zingg U. Incidence and prognostic factors for the development of symptomatic and asymptomatic marginal ulcers after Roux-en-Y gastric bypass procedures. Obes Surg. 2021;31:3005–14.
Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005;143(3):199–211.
Altieri MS, Pryor AD. Gastroesophageal reflux disease after bariatric procedures. Surg Clin. 2015;95(3):579–91.
Kindel TL, Oleynikov D. The improvement of gastroesophageal reflux disease and Barrett’s after bariatric surgery. Obes Surg. 2016;26:718–20.
Nickel F, Schmidt L, Bruckner T, Büchler MW, Müller-Stich B-P, Fischer L. Influence of bariatric surgery on quality of life, body image, and general self-efficacy within 6 and 24 months—a prospective cohort study. Surg Obes Relat Dis. 2017;13(2):313–9.
Felinska E, Billeter A, Nickel F, Contin P, Berlth F, Chand B, et al. Do we understand the pathophysiology of GERD after sleeve gastrectomy? Ann N Y Acad Sci. 2020;1482(1):26–35.
Mahawar KK, Borg C-M, Kular KS, Courtney MJ, Sillah K, Carr WR, et al. Understanding objections to one anastomosis (mini) gastric bypass: a survey of 417 surgeons not performing this procedure. Obes Surg. 2017;27:2222–8.
Yeung KTD, Penney N, Ashrafian L, Darzi A, Ashrafian H. Does sleeve gastrectomy expose the distal esophagus to severe reflux?: a systematic review and meta-analysis. Ann Surg. 2020;271(2):257–65.
Björklund P, Lönroth H, Fändriks L. Manometry of the upper gut following Roux-en-Y gastric bypass indicates that the gastric pouch and Roux limb act as a common cavity. Obes Surg. 2015;25:1833–41.
Tolone S, Cristiano S, Savarino E, Lucido FS, Fico DI, Docimo L. Effects of omega-loop bypass on esophagogastric junction function. Surg Obes Relat Dis. 2016;12(1):62–9.
Kermansaravi M, Parmar C, Chiappetta S, Shahabi S, Abbass A, Abbas SI, et al. Patient selection in one anastomosis/mini gastric bypass—an expert modified delphi consensus. Obes Surg. 2022;32(8):2512–24.
Spechler SJ, Souza RF. Barrett's esophagus. N Engl J Med. 2014;371(9):836–45.
Brown WA, Johari Halim Shah Y, Balalis G, Bashir A, Ramos A, Kow L, et al. IFSO position statement on the role of esophago-gastro-duodenal endoscopy prior to and after bariatric and metabolic surgery procedures. Obes Surg. 2020;30(8):3135–53.
Mahawar K, Reed A, Graham Y. Marginal ulcers after one anastomosis (mini) gastric bypass: a survey of surgeons. Clin Obes. 2017;7(3):151–6.
Coblijn UK, Goucham AB, Lagarde SM, Kuiken SD, van Wagensveld BA. Development of ulcer disease after Roux-en-Y gastric bypass, incidence, risk factors, and patient presentation: a systematic review. Obes Surg. 2014;24:299–309.
Rodrigo D-C, Jill S, Daniel M, Kimberly C, Maher EC. Which factors correlate with marginal ulcer after surgery for obesity? Obes Surg. 2020;30:4821–7.
Kermansaravi M, Mahawar KK, Davarpanah Jazi AH, Eghbali F, Kabir A, Pazouki A. Revisional surgery after one anastomosis/mini gastric bypass: A narrative review. J Res Med Sci. 2020;25:62.
Mahawar KK, Jennings N, Brown J, Gupta A, Balupuri S, Small PK. “Mini” gastric bypass: systematic review of a controversial procedure. Obes Surg. 2013;23:1890–8.
Rutledge R, Walsh TR. Continued excellent results with the mini-gastric bypass: six-year study in 2,410 patients. Obes Surg. 2005;15(9):1304–8.
Nelson LG, Gonzalez R, Haines K, Gallagher SF, Murr MM. Amelioration of gastroesophageal reflux symptoms following Roux-en-Y gastric bypass for clinically significant obesity. Am Surg. 2005;71(11):950–4.
Adil MT, Al-Taan O, Rashid F, Munasinghe A, Jain V, Whitelaw D, et al. A systematic review and meta-analysis of the effect of roux-en-Y gastric bypass on Barrett’s esophagus. Obes Surg. 2019;29:3712–21.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics statement
This meta-analysis paper is based on previously published studies and does not involve any direct participation of human or animal subjects.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Key Points
• The current study showed a relatively low rate of gastroesophageal reflux and its complications after OAGB.
• OAGB had a significantly higher rate of new-onset reflux than Roux-en-Y gastric bypass.
• Studies with sample sizes > 500 had a 3% rate of new-onset reflux versus 7% for studies with lower sample sizes.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Esparham, A., Ahmadyar, S., Zandbaf, T. et al. Does One-Anastomosis Gastric Bypass Expose Patients to Gastroesophageal Reflux: a Systematic Review and Meta-analysis. OBES SURG 33, 4080–4102 (2023). https://doi.org/10.1007/s11695-023-06866-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-023-06866-y